CAPEOX: clinical trials recruiting now
4
Recruiting trials
6
Conditions studied
25
US states with sites
29
Countries
Phase breakdown
Phase 2 3
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer · CAPEOX for Colorectal cancer | 4 |
| Neoplasms, Colon | 2 |
| Colon Adenocarcinoma | 1 |
| Colonic Neoplasms | 1 |
| Locally Advanced | 1 |
| Rectal Cancer | 1 |
Recruiting trials involving CAPEOX
- A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
- HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
- SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
- Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Common questions
How many recruiting trials involve CAPEOX?
4 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.